InvestorIdeas.com | big ideas for the small cap investor

search subscribe advertise submitnews

   research       membership       insiders corner       investor alerts       audio       marketplace       green investor       stock directories       trading center       JOBS     


$39.00 
(US funds) Per report



InvestorIdeas.com is pleased to provide research reports on the following:

 

Report Title:  China's Health System Reform: Implications for Drug Manufacturers
Prepared by Mr. Ki Chiu, Investment and Finance Consultant www.investorideas.com/About/ 

Summary:  Since mid 90s, the PRC (People Republic of China) government has formulated and implemented a number of new policies in a bid to reform its medical and health industry.  The medical reform aims to reduce medical expenses, shift financial burden from the State to corporations and improve quality of medical services, social welfare and efficiency of resource allocation.  It is expected that demand for medical services will rise as a result.  However, the impact of the reform on various operators in the pharmaceutical manufacturing industry is mixed.  The following is an analysis of major government policies and their impact on the drug manufacturers.

 

 

 

 

 

 

 

TOP

 

ECON Corporate Services, Inc.

© 2000 - 2008 InvestorIdeas.com®, ECON

about us | partners / links | company showcase | contact | employment | disclaimer | privacy policy | sitemap